N6-ciklopentiladenozin (Serbo-Croatian Wikipedia)

Analysis of information sources in references of the Wikipedia article "N6-ciklopentiladenozin" in Serbo-Croatian language version.

refsWebsite

Global rank Serbo-Croatian rank

8doi.org

2^nd place

8nih.gov

4^th place

3^rd place

1sciencedirect.com

149^th place

32^nd place

1wikipedia.org

low place

1archive.org

6^th place

5^th place

archive.org

Williams M, Braunwalder A, Erickson TJ (February 1986). „Evaluation of the binding of the A-1 selective adenosine radioligand, cyclopentyladenosine (CPA), to rat brain tissue”. Naunyn-Schmiedeberg's Archives of Pharmacology 332 (2): 179–83. DOI:10.1007/BF00511410. PMID 3703020.

doi.org

dx.doi.org

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
Williams M, Braunwalder A, Erickson TJ (February 1986). „Evaluation of the binding of the A-1 selective adenosine radioligand, cyclopentyladenosine (CPA), to rat brain tissue”. Naunyn-Schmiedeberg's Archives of Pharmacology 332 (2): 179–83. DOI:10.1007/BF00511410. PMID 3703020.
Zablocki JA, Wu L, Shryock J, Belardinelli L (2004). „Partial A(1) adenosine receptor agonists from a molecular perspective and their potential use as chronic ventricular rate control agents during atrial fibrillation (AF)”. Current Topics in Medicinal Chemistry 4 (8): 839–54. DOI:10.2174/1568026043450998. PMID 15078215.
Hutchinson SA, Scammells PJ (2004). „A(1) adenosine receptor agonists: medicinal chemistry and therapeutic potential”. Current Pharmaceutical Design 10 (17): 2021–39. DOI:10.2174/1381612043384204. PMID 15279543.
Elzein E, Kalla R, Li X, Perry T, Marquart T, Micklatcher M, Li Y, Wu Y, Zeng D, Zablocki J (January 2007). „N6-Cycloalkyl-2-substituted adenosine derivatives as selective, high affinity adenosine A1 receptor agonists”. Bioorganic & Medicinal Chemistry Letters 17 (1): 161–6. DOI:10.1016/j.bmcl.2006.09.065. PMID 17045477.
Elzein E, Zablocki J (December 2008). „A1 adenosine receptor agonists and their potential therapeutic applications”. Expert Opinion on Investigational Drugs 17 (12): 1901–10. DOI:10.1517/13543780802497284. PMID 19012505.
Franchetti P, Cappellacci L, Vita P, Petrelli R, Lavecchia A, Kachler S, Klotz KN, Marabese I, Luongo L, Maione S, Grifantini M (April 2009). „N6-Cycloalkyl- and N6-bicycloalkyl-C5'(C2')-modified adenosine derivatives as high-affinity and selective agonists at the human A1 adenosine receptor with antinociceptive effects in mice”. Journal of Medicinal Chemistry 52 (8): 2393–406. DOI:10.1021/jm801456g. PMID 19317449.

nih.gov

ncbi.nlm.nih.gov

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
Williams M, Braunwalder A, Erickson TJ (February 1986). „Evaluation of the binding of the A-1 selective adenosine radioligand, cyclopentyladenosine (CPA), to rat brain tissue”. Naunyn-Schmiedeberg's Archives of Pharmacology 332 (2): 179–83. DOI:10.1007/BF00511410. PMID 3703020.
Coffin VL, Spealman RD (April 1987). „Behavioral and cardiovascular effects of analogs of adenosine in cynomolgus monkeys”. The Journal of Pharmacology and Experimental Therapeutics 241 (1): 76–83. PMID 3572798.
Zablocki JA, Wu L, Shryock J, Belardinelli L (2004). „Partial A(1) adenosine receptor agonists from a molecular perspective and their potential use as chronic ventricular rate control agents during atrial fibrillation (AF)”. Current Topics in Medicinal Chemistry 4 (8): 839–54. DOI:10.2174/1568026043450998. PMID 15078215.
Hutchinson SA, Scammells PJ (2004). „A(1) adenosine receptor agonists: medicinal chemistry and therapeutic potential”. Current Pharmaceutical Design 10 (17): 2021–39. DOI:10.2174/1381612043384204. PMID 15279543.
Elzein E, Kalla R, Li X, Perry T, Marquart T, Micklatcher M, Li Y, Wu Y, Zeng D, Zablocki J (January 2007). „N6-Cycloalkyl-2-substituted adenosine derivatives as selective, high affinity adenosine A1 receptor agonists”. Bioorganic & Medicinal Chemistry Letters 17 (1): 161–6. DOI:10.1016/j.bmcl.2006.09.065. PMID 17045477.
Elzein E, Zablocki J (December 2008). „A1 adenosine receptor agonists and their potential therapeutic applications”. Expert Opinion on Investigational Drugs 17 (12): 1901–10. DOI:10.1517/13543780802497284. PMID 19012505.
Franchetti P, Cappellacci L, Vita P, Petrelli R, Lavecchia A, Kachler S, Klotz KN, Marabese I, Luongo L, Maione S, Grifantini M (April 2009). „N6-Cycloalkyl- and N6-bicycloalkyl-C5'(C2')-modified adenosine derivatives as high-affinity and selective agonists at the human A1 adenosine receptor with antinociceptive effects in mice”. Journal of Medicinal Chemistry 52 (8): 2393–406. DOI:10.1021/jm801456g. PMID 19317449.

sciencedirect.com

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

wikipedia.org

sh.wikipedia.org

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit